Schedule 13D ownership disclosure

Compass Therapeutics Inc

Security class unavailable · CUSIP: 20454B104

Event date: 2022-11-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.1700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-282853
Form type
SC 13D
Filer
Commander Aggregator, LP
CIK
CIK 1953093
Filed
Nov 14, 2022
Reporting period
Nov 04, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub